RecallDepth
Class II Terminated

Duloxetine Delayed-Release Capsules USP, 20 mg, packaged in a) 30 Unit Doses (3x10 blister packs) NDC 0904-7043-04 and b) 100 Unit Doses (10x10 blister packs) NDC 0904-7043-61, Rx only, Packaged and Distributed by: Major Pharmaceuticals, Indianapolis, IN 46268 USA.

Company
The Harvard Drug Group Llc Dba Major Pharmaceuticals And Rugby Laboratories
Recall Initiated
January 13, 2025
Posted
February 5, 2025
Recall Number
D-0212-2025
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
a) 6408 boxes and b)1488 boxes
Firm Location
La Vergne, TN, United States

Reason for Recall

CGMP Deviations: presence of Nitrosamine Drug Substances Related Impurity (NDSRI), N-Nitroso-Duloxetine above the FDA recommended acceptable intake limit

Distribution

Nationwide within the United States

Lot / Code Info

Lot #: a) N01530, Exp. Date 01/2025; b) N01540, Exp. Date. 01/2025

More recalls by The Harvard Drug Group Llc Dba Major Pharmaceuticals And Rugby Laboratories

View all recalls by this company →

Other recent Class II Drug recalls